Pelican Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2009-01-01
- Employees
- 1
- Market Cap
- -
PTX-35 in Patients With Advanced Solid Tumors
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Pelican Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04430348
- Locations
- 🇺🇸
Next Oncology, San Antonio, Texas, United States
🇺🇸NEXT Oncology Austin, Austin, Texas, United States
🇺🇸Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, Oregon, United States
© Copyright 2025. All Rights Reserved by MedPath